178 related articles for article (PubMed ID: 14960659)
1. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
4. Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration.
Boros E; Ferreira CL; Cawthray JF; Price EW; Patrick BO; Wester DW; Adam MJ; Orvig C
J Am Chem Soc; 2010 Nov; 132(44):15726-33. PubMed ID: 20958034
[TBL] [Abstract][Full Text] [Related]
5. Processing of generator-produced 68Ga for medical application.
Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
[TBL] [Abstract][Full Text] [Related]
6. Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography.
Schuhmacher J; Klivényi G; Matys R; Stadler M; Regiert T; Hauser H; Doll J; Maier-Borst W; Zöller M
Cancer Res; 1995 Jan; 55(1):115-23. PubMed ID: 7805020
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 68Ga-labeled tracers for PET imaging of myocardial perfusion in pigs.
Tarkia M; Saraste A; Saanijoki T; Oikonen V; Vähäsilta T; Strandberg M; Stark C; Tolvanen T; Teräs M; Savunen T; Green MA; Knuuti J; Roivainen A
Nucl Med Biol; 2012 Jul; 39(5):715-23. PubMed ID: 22264857
[TBL] [Abstract][Full Text] [Related]
8. Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
Griffiths GL; Chang CH; McBride WJ; Rossi EA; Sheerin A; Tejada GR; Karacay H; Sharkey RM; Horak ID; Hansen HJ; Goldenberg DM
J Nucl Med; 2004 Jan; 45(1):30-9. PubMed ID: 14734668
[TBL] [Abstract][Full Text] [Related]
9. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
[TBL] [Abstract][Full Text] [Related]
10. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
Chakravarty R; Chakraborty S; Dash A; Pillai MR
Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
12. Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature.
Velikyan I; Maecke H; Langstrom B
Bioconjug Chem; 2008 Feb; 19(2):569-73. PubMed ID: 18205327
[TBL] [Abstract][Full Text] [Related]
13. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
16. [The study of the effect of antisense oligonucleotide specific to K-ras point mutation on human pancreatic carcinoma cell PC-2].
Wang YX; Gao L; Ji ZZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1387-90. PubMed ID: 16318775
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Ujula T; Huttunen M; Luoto P; Peräkylä H; Simpura I; Wilson I; Bergman M; Roivainen A
Bioconjug Chem; 2010 Sep; 21(9):1612-21. PubMed ID: 20795647
[TBL] [Abstract][Full Text] [Related]
19. Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?
Pagou M; Zerizer I; Al-Nahhas A
Hell J Nucl Med; 2009; 12(2):102-5. PubMed ID: 19675859
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
Geary RS; Watanabe TA; Truong L; Freier S; Lesnik EA; Sioufi NB; Sasmor H; Manoharan M; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):890-7. PubMed ID: 11181921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]